NETRAMARK
LIVE

Serial Number

97813502

Owner

NetraMark Corp.

Attorney

James M. Urzedowski

Filing Date

Feb 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NETRAMARK Trademark

Serial Number: 97813502

NETRAMARK is a trademark filed by NetraMark Corp. on February 27, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

NetraMark Corp. (2 trademarks)

Suite 101
Toronto, ON M6P3T1 , CA

Entity Type: 03

Trademark Details

Filing Date

February 27, 2023

Registration Date

Not Registered

Goods & Services

Business consulting services concerning the regulatory approval process for pharmaceuticals; providing independent review of clinical trials in the pharmaceutical, biotechnology and life sciences fields for business purposes; providing consulting services in the field of regulatory submission management to pharmaceutical companies to assist them with applications for pharmaceutical regulatory approval

Scientific analysis of clinical trials in the pharmaceutical, biotechnology and life sciences fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting chemical molecular analysis, designing and testing new products to optimize efficacy, and conducting clinical trials, all for pharmaceutical industries; Software as a service (SaaS) services featuring software for analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; software as a service (SaaS) services featuring software for analyzing molecular and clinical data for scientific and medical research; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of pharmaceutical regulatory approval; providing online non-downloadable computer system software for the integration of artificial intelligence and machine learning in the field of big data for business data analytics and clinical trial analytics

Downloadable and recorded computer software for analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; downloadable and recorded computer software for analyzing molecular and clinical data for scientific and medical research; downloadable and recorded computer software for data automation and data collection to evaluate, analyze and collect clinical research data in the field of clinical trials; downloadable and recorded computer system software for the integration of artificial intelligence and machine learning in the field of big data for business data analytics and clinical trial analytics

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 18, 2026 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 1, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 1, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 10, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 10, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 10, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 23, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 22, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 22, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jan 22, 2025 CNSL
ASSIGNED TO LIE
Jan 22, 2025 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 2, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 31, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 31, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 31, 2024 CNSI
CORRESPONDENCE E-MAILED
Jan 29, 2024 GRML
SUSPENSION LETTER WRITTEN
Jan 29, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 28, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 28, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2023 NWOS
NEW APPLICATION ENTERED
Mar 2, 2023 NWAP